Bumble Inc. (BMBL): restructuring charge — Bumble cuts ~240 roles (30% of staff); updates Q2 outlook

Bumble Inc.

Workforce reduction of ~240 roles (~30% of employees); expects $13-18M in severance/benefit charges.
Expects up to $40M in annual cost savings, mostly reinvested in product and tech development.
Updated Q2 2025 outlook: revenue $244-249M, adjusted EBITDA $88-93M.
Charges to be incurred primarily in Q3 and Q4 2025, with some extensions due to local consultation laws.

Key facts

Extracted from this filing and checked against the source text.

Restructurings & Charges SEC 8-K Item 2.05/2.06 confidence 0.9

Bumble Inc. announced a restructuring with charges of approximately $13 million to $18 million of non-recurring charges (approximately 240 roles, representing approximately 30% of the Company's employees).

Type: restructuring
Charge: approximately $13 million to $18 million of non-recurring charges
Headcount: approximately 240 roles, representing approximately 30% of the Company's employees

Exact text from the filing

On June 23, 2025, the Board of Directors of Bumble Inc. (the “Company”) approved a reduction in the Company’s global workforce by approximately 240 roles, representing approximately 30% of the Company’s employees, as the Company realigns its operating structure to optimize execution on its strategic priorities. As a result, the Company expects to incur approximately $13 million to $18 million of non-recurring charges, consisting primarily of employee severance, benefits, and related charges, for impacted employees.

View on SEC.gov

2 restructurings & charges filed in the last 30 days. Browse all restructurings & charges →

Bumble Inc. filing history →

Source: SEC EDGAR

accession 0001193125-25-146199

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.